Norovirus evolves as one or more distinct clonal populations in immunocompromised hosts
mBio · 19.12.2023 · 14 (6)
DOI: 10.1128/mbio.02177-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, erschienen am 19.12.2023. Verfasst von Natthawan Chaimongkol und 13 weiteren Autor:innen. Beteiligte Einrichtung: Caliciviruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethe…. Hauptthemen laut MEDLINE: Norovirus, Immunocompromised Host, Caliciviridae Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | NIH | NIAID | Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID), HHS | U.S. Food and Drug Administration (FDA).
Abstract (Originalsprache)
Noroviruses are a major cause of acute gastroenteritis worldwide and can establish chronic infection in immunocompromised individuals. To investigate the mechanisms of norovirus evolution during chronic infection, we selected seven representative patients from a National Institutes of Health study cohort who sustained norovirus infection for periods ranging from 73 to 1,492 days. Six patients shed viruses belonging to a single genotype (GII.2[PNA], GII.4 New Orleans[P4], GII.4 Den Haag[P4], GII.3[P21], GII.6[P7], or GII.14[P7]) over the period examined, while one patient sequentially shed two genotypes (GII.6[P7] followed by GII.4 Sydney[P31]). Norovirus genomes from consecutive stool samples were sequenced at high resolution (>3,300 reads/nucleotide position) using the Illumina platform and subjected to bioinformatics analysis. Norovirus sequences could be resolved into one or more discrete clonal RNA genomes that persisted within these patients over time. Phylogenetic analyses inferred that clonal populations originated from a single founder virus and not by reinfection with community strains. Estimated evolutionary rates of clonal populations during persistent infection were similar to those of noroviruses from acute infection in the global database, suggesting that inherently higher RNA-dependent polymerase error rates were not associated with the ability to persist. The high-resolution analysis of norovirus diversity and evolution at the population level described here should allow a better understanding of adaptive mutations sustained during chronic infection. IMPORTANCE Noroviruses are an important cause of chronic diarrhea in patients with compromised immune systems. Presently, there are no effective therapies to clear the virus, which can persist for years in the intestinal tract. The goal of our study was to develop a better understanding of the norovirus strains that are associated with these long-term infections. With the remarkable diversity of norovirus strains detected in the immunocompromised patient cohort we studied, it appears that most, if not all, noroviruses circulating in nature may have the capacity to establish a chronic infection when a person is unable to mount an effective immune response. Our work is the most comprehensive genetic data set generated to date in which near full-length genomes from noroviruses associated with chronic infection were analyzed by high-resolution next-generation sequencing. Analysis of this data set led to our discovery that certain patients in our cohort were shedding noroviruses that could be subdivided into distinct haplotypes or populations of viruses that were co-evolving independently. The ability to track haplotypes of noroviruses during chronic infection will allow us to fine-tune our understanding of how the virus adapts and maintains itself in the human host, and how selective pressures such as antiviral drugs can affect these distinct populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Caliciviruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- Laboratory of Virology and Cell Culture, Institute of Tropical Pathology and Public Health, Federal University of Goiás, Goiânia, Goiás, Brazil.
- Division of Viral Products, Food and Drug Administration, Silver Spring, Maryland, USA.
- Bioinformatics and Computational Biosciences Branch, Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, US…
ORCID-Profile: Natthawan Chaimongkol, Gabriel I Parra, Kim Y Green
Förderung
- HHS | NIH | NIAID | Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID)
- HHS | U.S. Food and Drug Administration (FDA)
Zitieren
APA
Chaimongkol, N., Dábilla, N., Tohma, K., Matsushima, Y., Yardley, A. B., Levenson, E. A., Johnson, J. A., Ahorrio, C., Oler, A. J., Kim, D. Y., Souza, M., Sosnovtsev, S. V., Parra, G. I., & Green, K. Y. (2023). Norovirus evolves as one or more distinct clonal populations in immunocompromised hosts. mBio, 14(6). https://doi.org/10.1128/mbio.02177-23
Vancouver
Chaimongkol N, Dábilla N, Tohma K, Matsushima Y, Yardley AB, Levenson EA, et al. Norovirus evolves as one or more distinct clonal populations in immunocompromised hosts. mBio. 2023;14(6). doi:10.1128/mbio.02177-23
BibTeX
@article{Chaimongkol2023,
author = {Chaimongkol, Natthawan and Dábilla, Nathânia and Tohma, Kentaro and Matsushima, Yuki and Yardley, Allison Behrle and Levenson, Eric A and Johnson, Jordan A and Ahorrio, Courtney and Oler, Andrew J and Kim, Daniel Y and Souza, Menira and Sosnovtsev, Stanislav V and Parra, Gabriel I and Green, Kim Y},
title = {Norovirus evolves as one or more distinct clonal populations in immunocompromised hosts},
journal = {mBio},
year = {2023},
volume = {14},
number = {6},
doi = {10.1128/mbio.02177-23}
}
EUVIMED